EssilorLuxottica (OTCMKTS:ESLOY) Stock Rating Upgraded by Hsbc Global Res

EssilorLuxottica (OTCMKTS:ESLOY) was upgraded by Hsbc Global Res to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports.

Other research analysts have also issued research reports about the company. UBS Group upgraded EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. Citigroup reissued a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Zacks Research downgraded shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of EssilorLuxottica in a research note on Tuesday, October 28th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

EssilorLuxottica Trading Down 0.0%

EssilorLuxottica stock opened at $162.99 on Wednesday. EssilorLuxottica has a 12-month low of $123.09 and a 12-month high of $186.81. The firm has a 50-day moving average price of $169.59 and a 200-day moving average price of $161.64. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.67 and a current ratio of 0.97.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.